×
About 70,265 results

Single Chest X-Ray Could Predict 10-Year CVD Risk
https://www.medscape.com/viewarticle/984910

Dec 2nd, 2022 - CHICAGO ― A single chest x-ray could predict a patient's 10-year risk of dying from a heart attack or stroke, say researchers who presented the results of their deep-learning model at the Radiological Society of North America (RSNA) 2022 Annual Meeting. Current American College of Cardiologists (ACC) and American Heart Association (AHA) guidelines recommend estimating 10-year risk of major adve...

Trending Clinical Topic: Weight Loss Drugs
https://www.medscape.com/viewarticle/984313

Dec 2nd, 2022 - Each week, we identify one top search term, speculate about what caused its popularity, and provide an infographic on a related condition. If you have thoughts about what's trending and why, share them with us on Twitter or Facebook.  Excitement about "unprecedented" weight loss associated with tirzepatide, news about other injectable medications, and updated antiobesity recommendations resulte...

Unique Nationwide Screening Program Fails to Move the Needle on CVD Risk Factors
https://www.medpagetoday.com/primarycare/preventivecare/102002

Dec 1st, 2022 - Japan's mass screening and counseling intervention resulted in only modest population-wide improvements in obesity and cardiovascular disease (CVD) risk factors, a study showed. Among over 3.4 million men and 2.3 million women, those who met the threshold for high waist circumference with high blood pressure, impaired glucose tolerance, or dyslipidemia and received lifestyle guidance and counse...

Shorter Intervals Between Meals Linked to Higher Mortality
https://www.medscape.com/viewarticle/984849

Dec 1st, 2022 - A shorter time interval of 4.5 hours or fewer between meals is associated with increased risk of all-cause mortality compared with longer intervals, according to a large, new prospective study that looked at both frequency of and intervals between meals in US adults 40 years of age and older. The study also indicates that eating one meal per day — compared with three — is associated with higher...

How to Diagnose Circulatory Disorders in Diabetes
https://www.medscape.com/viewarticle/984854

Dec 1st, 2022 - "In Germany, a patient dies every 20 minutes from mostly vascular-related events caused by diabetes," said Berthold Amann, MD, conference president of the German Society for Angiology (DGA). He spoke at the press conference of the Diabetes Autumn Conference of the German Diabetes Society (DDG), which was held in cooperation with the DGA. Because stenoses and occlusions in the arteries of the pe...

Both Potatoes and Beans Reduced Insulin Resistance, Weight in Controlled Study
https://www.medscape.com/viewarticle/984876

Dec 1st, 2022 - Low energy–density diets that are based either on potatoes or beans similarly reduced insulin resistance in adults with poor blood glucose control, according to a controlled feeding study in 36 individuals. Potatoes have gotten a bad rap for their high glycemic index, but they have little fat and a low energy density, wrote the study investigators. In fact, "cooling of gelatinized potatoes gene...

TikTok Creates Ozempic Shortage; New MS Framework Proposed; and AI May Cut Bias in Drug Trials
https://www.medscape.com/viewarticle/984741

Dec 1st, 2022 - TikTok Creates Ozempic Shortage TikTok is fueling demand for Ozempic, creating shortages of the diabetes drug now used for weight loss. Videos on TikTok hashtagged #ozempic have amassed more than 275 million views, and #ozempicweightloss has more than 110 million. The trend follows social media posts by celebrities such as Kim Kardashian and Elon Musk touting their own use of the drug or weight...

Is It Time to Write a Prescription for Meditation Instead of Medication in Type 2 Diabetes?
https://www.medscape.com/viewarticle/984551

Nov 30th, 2022 - A recently published meta-analysis suggested that the utilization of mind-body practices in people living with type 2 diabetes can help significantly improve glycemic control. Multiple media outlets extolled the findings that these techniques could lead to a mean A1c reduction of 0.84%, which is similar to or better than what is achieved with many pharmacotherapies developed for the management ...

With Type 1 Diabetes Delay Possible, Focus Now on Screening
https://www.medscape.com/viewarticle/984748

Nov 30th, 2022 - The recent approval of teplizumab-mzwv (Tzield, Provention Bio) for the delay of type 1 diabetes by the US Food and Drug Administration is expected to advance efforts to increase screening to cost-effectively identify those at risk for the condition who would be eligible to receive the new treatment. The anti-CD3 monoclonal antibody was approved November 17 as the first disease-modifying therap...

The TikTok Trend That Triggered a Diabetes Drug Shortage
https://www.medscape.com/viewarticle/984758

Nov 30th, 2022 - Weight loss advice is everywhere you look on social media, but one trend sweeping TikTok has led to shortages of an important diabetes drug.  Ozempic, a weekly injection that helps boost insulin sensitivity in people with type 2 diabetes, also suppresses appetite, which leads to weight loss. Stories of celebrities using the drug off-label to lose a few pounds have led to an explosion of interes...

New Genetic Variant Linked to Maturity-Onset Diabetes of the Young
https://www.medscape.com/viewarticle/984757

Nov 30th, 2022 - A newly discovered genetic variant that is associated with type 2 diabetes (T2D) is responsible for almost 7% of all diabetes cases in Greenland, according to a whole-genome sequencing analysis of 448 Greenlandic Inuit individuals. The variant, identified as c.1108G>T, "has the largest population impact of any previously reported variant" within the HNF1A gene – a gene that can cause maturity-o...

Ultra-Long Stroke Transfers; Isotopes Return; Back-to-Back CPR During Half Marathon
https://www.medpagetoday.com/cardiology/prevention/101958

Nov 29th, 2022 - Persistent asthma was linked to higher carotid plaque burden and inflammation in the MESA cohort. (Journal of the American Heart Association) Hospitals can still make endovascular therapy work for stroke patients transferred from over 300 miles away, suggested a retrospective study from New Zealand and Australia. (Stroke) Good news during the medical radioisotope shortage: the global supply of ...

Albuminuria Remission With Meds; Tzield's High Cost; Osteoporosis Prevention Lags
https://www.medpagetoday.com/endocrinology/generalendocrinology/101956

Nov 29th, 2022 - "Best" medical treatment with drugs such as SGLT2 inhibitors and GLP-1 receptor agonists was just as effective as Roux-en-Y gastric bypass at achieving albuminuria remission in patients with diabetic kidney disease and class I obesity. (eClinicalMedicine) Men with metabolic syndrome, and particularly those with obesity and high triglycerides, had a higher risk for developing gout in a study of ...

Lupus Linked With Greater Risk of Cardiovascular Complications of Childbirth
https://www.medpagetoday.com/rheumatology/lupus/101954

Nov 29th, 2022 - Pregnant women with systemic lupus erythematosus (SLE) were more prone to cardiovascular complications during delivery, and their risk seems to have increased over the past 15 years, according to national administrative data. The cross-sectional study supports the role that the underlying inflammatory activity of SLE may play in these cardiovascular complications, since even after adjustment fo...

We Have an Amputation Epidemic
https://www.medscape.com/viewarticle/984461

Nov 29th, 2022 - Every three minutes in America, a person loses all or part of a limb due to their diabetes. Every. Three. Minutes. Robert A. Gabbay, MD, PhD Five-year mortality numbers for individuals undergoing a diabetes-related amputation rival those of many forms of cancer. Tragically, your odds of suffering from limb loss can come down to the color of your skin, your gender, your educational level, where ...

AFib Risk Rises as A1c Increases
https://www.medscape.com/viewarticle/984714

Nov 29th, 2022 - Researchers published the study covered in this summary on Research Square as a preprint that has not yet been peer reviewed. Key Takeaways Adults not receiving glucose-lowering drugs showed a stepwise, increasing risk of developing atrial fibrillation (AFib) that tracked with increasing levels of A1c from 5.8% to 7.6% (40 to 60 mmol/mol). Patients with new-onset diabetes had a similar risk of ...

Don't Skip Exercise in Lifestyle Interventions for Kids With Obesity
https://www.medpagetoday.com/pediatrics/obesity/101939

Nov 28th, 2022 - Exercise is a key component of a family-based lifestyle intervention program aimed at helping kids lose fat, according to a secondary analysis of a nonrandomized controlled trial. Over the 22-week program, kids with overweight or obesity whose families participated in a lifestyle intervention program with supervised exercise training saw an 18.1% reduction in visceral adipose tissue (VAT) versu...

Factors of Variable Glycemic Control
https://tools.cdc.gov/medialibrary/index.aspx#/media/id/361382

Although glycemic control is known to reduce complications associated with diabetes, it is an elusive goal for many patients who have the disease. This study aims to identify factors associated with sustained poor glycemic control, some glycemic variability, and wide glycemic variability among diabetes patients over 3 years.

Fire Hazard Alert About Omnipod 5 'Artificial Pancreas' Charger
https://www.medscape.com/viewarticle/984602

Nov 25th, 2022 - Insulet has alerted users of the Omnipod 5 Automated Insulin Delivery (AID) System about a potential fire hazard with the controller device's battery charger. The Medical Device Correction notice issued November 14 is not a recall; rather, users are advised to check the charging port on the controller to see if it is "melted, deformed, or discolored," or if the device overheats or emits an odor...

Second Biosimilar Insulin OK'd; Diabetes Risk After COVID; Omnipod DASH Recall
https://www.medpagetoday.com/endocrinology/generalendocrinology/101867

Nov 22nd, 2022 - The FDA approved the second interchangeable biosimilar insulin product, Eli Lilly's insulin glargine-aglr (Rezvoglar), for pediatric and adult patients with diabetes, the agency announced. Patients with diabetes and chronic kidney disease should be considered for simultaneous pancreas-kidney transplantation independent of geography or location, said authors of a review on pancreas transplantati...